Gt Biopharma, Inc: Theorem Group Opened Position

November 14, 2017 - By Michael Collier

 Gt Biopharma, Inc: Theorem Group Opened Position

The New Theorem Group Holding in Gt Biopharma, Inc

Theorem Group reported SC 13G form with the SEC for Gt Biopharma, Inc. Access it here: 000093979817000081. As reported by Theorem Group, the filler owns 7.1% or 3,540,130 shares of the -company.

Gt Biopharma, Inc stake is new for [reportingPerson]. Date of activity: September 1, 2017. This shows Theorem Group’s positive view for Gt Biopharma, Inc.

SEC Form 13G.

It is down 0.00% since November 14, 2016 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.